Asthma Trial, Recruiting NCT06623981 Sponsor: Children's National Research Institute Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06623981
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the mother/primary caregiver:

  • The primary caregiver of the child with asthma must be a woman (self-identified) who identifies as Black
  • The caregiver must be 18 years of age or older
  • The caregiver must speak English
  • The caregiver must be the main person looking after the child and attending the community-based asthma clinic
  • The caregiver must score 8 or higher on a standard depression screening questionnaire (the PHQ-9) taken during the child's clinic visit

For the child:

  • The child must be under 18 years old for the full 6-month study period
  • The child must have health insurance through a public program (such as Medicaid)
  • The child must have been diagnosed by a doctor with persistent asthma

Who may not be able to join:

For the mother/primary caregiver:

  • Caregivers who are assessed as being at high risk of suicide at the time of the child's clinic visit
  • Caregivers who have a diagnosis of bipolar disorder or mania
  • Caregivers who have a diagnosis of schizophrenia
  • Caregivers who are currently experiencing substance use or dependence issues
  • Caregivers who are currently in a situation involving serious physical violence from a partner
  • Caregivers who, based on staff assessment during screening, are not able to meaningfully take part in the study activities

For the child:

  • Children who have significant other health conditions alongside asthma, such as heart or breathing disorders, serious developmental delays, diabetes, seizure disorders, or sickle cell disease
  • Children who are already taking part in another study that involves a behavioural program or a new type of asthma treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rachel Margolis, PhD, MSW, Children's National Research Institute

Phone: (202) 476-6956

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's National Research Institute
Registry
ClinicalTrials.gov
Start date
15 October 2024
Est. completion
15 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Maternal depressive symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov